Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins

Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain containing proteins

US Patent 10696670 · Granted Jun 30, 2020

Estimated economic value: $8,462,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Cannabinoid derivatives2025
Cannabinoid derivatives2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2022
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2022
Fluorinated amide derivatives and their uses as therapeutic agents2020
Heterocycle derivatives and their use for the treatment of CNS disorders2019
Fluorinated imidazo[4,5-C]quinoline derivatives as inhibitors of bromodomain con2019